about
Airway Gland Structure and FunctionThe role of disposable inhalers in pulmonary drug delivery.Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.Transcytosis: crossing cellular barriers.Cigarette smoke inhibits BAFF expression and mucosal immunoglobulin A responses in the lung during influenza virus infectionComparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves.Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.Alpha-1 antitrypsin is markedly decreased following pulmonary F. tularensis challengePspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonizationMast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.Effect of hyperoxia on pulmonary SIgA and its components, IgA and SC.Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis.An In Vivo and In Vitro Evaluation of the Mutual Interactions between the Lung and the Large IntestineOral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease.Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?Immunoglobulins: current understanding and future directions.Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival.Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.Antibodies to the polymeric immunoglobulin receptor with different binding and trafficking patterns.Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.Gene expression profiling in the lungs of pigs with different susceptibilities to Glässer's disease.Secretory component is cleaved by neutrophil serine proteinases but its epithelial production is increased by neutrophils through NF-kappa B- and p38 mitogen-activated protein kinase-dependent mechanisms.Flagellin/TLR5 signaling potentiates airway serous secretion from swine tracheal submucosal glands.Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.Different inflammatory mechanisms in lungs of severe and mild asthma: crosstalk of NF-kappa-B, TGFbeta1, Bax, Bcl-2, IL-4 and IgE.Toll-like receptor 4 potentiates Ca2+-dependent secretion of electrolytes from swine tracheal glands.Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases.Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal ColonisationThe Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation
P2860
Q28082284-3BF80EE6-1573-4AF3-9FF3-151B1A16C256Q30368417-98268020-74F8-4018-AAE0-862029765519Q34701517-AB125E92-248F-4C2E-A5AE-0EF73F7DE4D7Q35169907-47E25F9D-DC51-4C66-81A3-165A950800F5Q35190343-6CC9B9EC-57BD-4A5B-B89D-AB12153D4E66Q35751725-214A4117-2201-4053-8A58-6A5A48F0E1E9Q35784151-30CE9ABA-A374-482E-8313-580EA6C6008EQ35980104-58E2508A-EFCD-4F80-B94C-C20A672E43AEQ36097216-68225AB3-567E-48A4-BBE7-E6F871982784Q36158780-201E5646-EF05-4C63-A7BD-EF2628207F11Q36506030-34C920A9-830F-4113-AD45-161574ED2BEDQ36756839-C0490B44-9B0E-44CD-8C1D-D17E0D7E5A87Q36760903-719575F1-C50C-4738-AF95-0C834C75588FQ36804222-27CCA154-F320-4A75-8B1D-428D8535D3F6Q36927614-6E16ECA1-9E1F-49FB-8203-281CC0DEF2BFQ37029229-E9F9C4A9-EFBC-479A-8AE2-6D89D5D3EA0AQ37077719-7EEA8B31-E760-4046-9A11-7145EE7C3E49Q37156774-B78CEE5B-BA89-40C0-AF3B-6F02A63B5D3AQ37368041-60ED2469-CF22-4931-BC07-44BA2FF72A45Q38418872-DB1E0162-D602-4355-9A61-D0DA75DF114AQ39067335-4FEE6D3F-0CCB-444C-9967-B57E426A8AAEQ39416267-41CA3EE0-0C11-4371-9651-E18A56EC5384Q40206378-FC847127-32ED-4160-A34C-65FCABE207A1Q40402450-5D51AF13-BFED-4EAC-A7B0-80A07066D565Q42134586-6062E330-DEEA-4859-94E6-3DB54E22A6CEQ42157827-C08E2048-4089-4F49-B081-BFBE0C260D30Q44374313-E0424541-9523-4B4C-957D-DD49A771AE9DQ44608433-9AC4D704-3571-4D3C-A807-E8CEF089058DQ46848508-5064262F-388C-4BCD-9300-D0667D559B12Q51733926-973E9B99-5BE2-4493-8A00-5CD35CEBF98FQ54587116-7EC6964C-B9C3-44E4-A797-5F07B0C99814Q54777409-73FCE0B1-6B34-4E89-8999-C91CB3C23989Q58596157-D6153525-0B7A-41B2-B2B2-317E2DA2E441Q58795403-D60F8855-CBF8-4895-ABBF-514DD10E2F4F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lung mucosal immunity: immunoglobulin-A revisited.
@ast
Lung mucosal immunity: immunoglobulin-A revisited.
@en
Lung mucosal immunity: immunoglobulin-A revisited.
@nl
type
label
Lung mucosal immunity: immunoglobulin-A revisited.
@ast
Lung mucosal immunity: immunoglobulin-A revisited.
@en
Lung mucosal immunity: immunoglobulin-A revisited.
@nl
prefLabel
Lung mucosal immunity: immunoglobulin-A revisited.
@ast
Lung mucosal immunity: immunoglobulin-A revisited.
@en
Lung mucosal immunity: immunoglobulin-A revisited.
@nl
P2093
P1476
Lung mucosal immunity: immunoglobulin-A revisited.
@en
P2093
J P Vaerman
Y Ouadrhiri
P304
P356
10.1183/09031936.01.00228801
P577
2001-09-01T00:00:00Z